Cargando…
WS14.3 Virtual consultation in cystic fibrosis: an Italian experience
Autores principales: | Carnovale, V., Iacotucci, P., Medio, P., Ferrillo, L., Buonaurio, S., D'Ippolito, M., Celardo, A., Coughlin, S., Savi, D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Cystic Fibrosis Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192167/ http://dx.doi.org/10.1016/S1569-1993(21)00995-4 |
Ejemplares similares
-
Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study
por: Carnovale, Vincenzo, et al.
Publicado: (2022) -
WS14.4 Exploring cystic fibrosis patient and staff perceptions of the Virtual Healthcare Hub during the COVID-19 pandemic at the All Wales Adult Cystic Fibrosis Service
por: Birkin, E., et al.
Publicado: (2021) -
WS14.1 The effect of the COVID-19 pandemic on quality of life of adults with cystic fibrosis
por: Birkin, E., et al.
Publicado: (2021) -
WS07.06 CFTR impacts SARS-CoV-2 infection in cystic fibrosis
por: Bragonzi, A., et al.
Publicado: (2023) -
WS11.2 The psychological implications and health risks of cystic fibrosis preand post-CFTR modulator therapy
por: Keyte, R., et al.
Publicado: (2021)